GleamWall
中文EN

CTSO Cytosorbents Corp

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1175151 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.3%
TTM net income YoY-70.4%
TTM EPS YoY-205.0%
Revenue 3-yr CAGR0.3%
Net income 3-yr CAGR—

Margins

Gross margin72.9%
Operating margin-30.0%
Net margin-46.7%
FCF margin-18.7%
EBITDA margin-26.8%

Returns

ROE-521.5%
ROA-42.2%
ROIC (approx.)-39.8%
Asset turnover0.90x

Leverage & solvency

Liabilities / assets106.2%
Debt / equity—
Current ratio0.55x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.39x
Accruals ratio-25.7%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$37.06M$35.59M
Cost of revenue$10.57M$10.71M
Gross profit$26.49M$24.89M
SG&A expense$35.65M$33.73M
Operating income-$14.75M-$16.45M
Pretax income-$8.60M-$22.41M
Income tax-$401,000-$1.69M
Net income-$8.20M-$20.72M
EBITDA-$13.52M-$15.12M
EPS (basic)-0.13-0.38
EPS (diluted)-0.13-0.38
Weighted avg. shares (diluted)62.23M54.43M
Balance sheet
Cash & equivalents$6.25M$9.76M
Receivables$7.55M$7.32M
Inventory$5.28M$2.73M
Current assets$20.63M$21.60M
PP&E, net$7.82M$9.00M
Intangibles$3.23M$3.72M
Total assets$44.18M$47.37M
Current liabilities$9.71M$9.82M
Long-term debt$16.67M$14.00M
Total debt$16.67M$14.00M
Total liabilities$38.28M$36.27M
Shareholders' equity$5.90M$11.11M
Net debt$10.42M$4.23M
Shares outstanding3.14M54.83M
Cash flow statement
Operating cash flow-$12.38M-$14.43M
Capital expenditure$164,000$284,000
Free cash flow-$12.54M-$14.71M
Investing cash flow-$415,000-$669,000
Financing cash flow$9.31M$9.33M
Depreciation & amortization$1.23M$1.33M
Stock-based compensation$2.77M$3.76M

Free plan shows the latest 2 periods; Pro shows all 29 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.